pulmonary

投放时间: 2025-06-23 08:00:00
⚕️ Quickly Identify Low-Risk Febrile Neutropenia Patients Use the MASCC Risk Index in ONCOassist to assess which patients can be safely managed as outpatients, helping guide decisions around hospitalization and antibiotics. ✅ Fast and intuitive scoring ✅ Supports oncology decision-making ✅ Trusted by 95,000+ professionals worldwide 📲 Download the ONCOassist app — the free go-to tool for oncologists.
搜索关键词 Febrile Neutropenia risk, Oncology decision support, Medical app, ONCOassist app, MASCC Risk Index, outpatient management, antibiotic decisions, oncology professionals, medical scoring tool, healthcare professionals优势 Fast and intuitive scoring,Supports oncology decision-making,Trusted by many professionals
展示估值
49687
热度
4784
最新发现时间
2025-06-23 08:00:00
投放天数
210

平台 & 渠道

投放渠道 facebook
系统 pc
国家 美国
语言 英语

素材信息

素材类型
素材尺寸
主页ID8289873642116238611
主页名字ONCOassist

产品信息

产品名称ONCOassist
促销类型Soft Promotion
评分

适用范围

适用人群both
劣势Requires app download,May not be suitable for all healthcare settings
情感Confidence
人民币汇率走势
CNY
亚马逊热销榜
共 0 SKU 上次更新 NaN:NaN:NaN
类目: 切换分类
暂无数据
暂无数据
关注我们
新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有,未经许可,禁止以任何形式转载。